Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      MedQuist Reports Third Quarter 2010 Results


      News provided by

      MedQuist Inc.

      Nov 11, 2010, 04:30 ET

      Share this article

      Share this article


      MOUNT LAUREL, N.J., Nov. 11, 2010 /PRNewswire-FirstCall/ -- MedQuist Inc., (Nasdaq: MEDQ) a leading provider of integrated clinical documentation solutions for the U.S. healthcare industry announced its financial results for the third quarter ended September 30, 2010.

      Third Quarter Highlights:

      • Revenue increased by 34.0% to $102.9 million compared to $76.8 million for the same quarter in the prior year due primarily to the incremental volumes of the acquired Spheris operations.
      • Realized third quarter cost savings from the Spheris acquisition of $4.0 million and on track to achieve $7.0 million for fourth quarter, or annualized savings of $28.0 million.
      • Adjusted EBITDA increased 56.8% to $21.5 million, or 20.9% of net revenues versus 17.8% for the same quarter in the prior year, reflecting the benefits of realized synergies from the Spheris acquisition, increased technology utilization, and expanded offshore production. (For more information regarding Adjusted EBITDA and our use of this non-GAAP financial measure, please refer to the section titled "Use of non-GAAP Financial Information").
      • This is the first quarter reflecting the full impact of the results of Spheris, acquired April 22, 2010.

      "We are pleased with our operating performance for the third quarter of 2010," said CEO Peter Masanotti. "Our net revenues increased 34.0% during the third quarter compared to the same period in the prior year, due largely to third quarter of 2010 being the first full quarter that included the impact of the Spheris acquisition.  Historical Spheris volumes had been declining prior to our acquisition of this business, and although we believe we have stabilized these volumes, the carryover impact of historical losses may impact us in future periods.  Our increases in revenues were partially offset by the impact of pricing and lower non-core maintenance service revenues.

      "We increased Adjusted EBITDA by 56.8% over the prior year same quarter despite an increasingly competitive market environment as the Spheris acquisition helped expand our customer base and provided continuing opportunities to realize operating efficiencies. We continue to see improvements to our operating margins as a result of efficiencies gained through use of our speech recognition technologies and expanded use of offshore labor.  We are also pleased with the results of integration efforts from the Spheris acquisition and expect that the majority of the synergies associated with this acquisition will be realized by mid-year 2011."

      Third Quarter Results

      Net revenues increased $26.1 million, or 34.0%, to $102.9 million for the three months ended September 30, 2010 compared with $76.8 million for the three months ended September 30, 2009. The acquisition of Spheris contributed $32.8 million in net revenues for the three months ended September 30, 2010 versus the same period in the prior year.  This increase was offset by a decrease in legacy maintenance services revenues which were $4.1 million and $5.1 million for the three months ended September 30, 2010 and 2009, respectively.  Current year net revenues were also unfavorably impacted by effects of lower average pricing realized for our transcription services.  

      As a percentage of net revenues, cost of revenues decreased to 66.5% for the three months ended September 30, 2010 from 68.7% for the same period in 2009.  This improvement was achieved through leveraging speech recognition technologies and increased offshore production as well as overhead savings realized as a result of the Spheris integration efforts.  Our use of speech recognition technology increased from 59% of our volume in the third quarter of 2009 to 72% of our volume during the third quarter of 2010.  Additionally, expanded utilization of our offshore resources enabled us to increase our offshore production from 21% of our volume to 34% of our volume over this same period.

      Total operating costs and expenses increased by 30.5% to $89.6 million during the third quarter from $68.7 million in the prior year comparable period primarily due to the inclusion of incremental direct costs of revenues associated with the acquisition of Spheris and $0.8 million of acquisition related costs.  Amortization expense increased by $1.9 million during the current year period versus the same comparable period in the prior year primarily due to amortization of acquired intangible assets associated with the acquisition of Spheris.  Also included in the third quarter results were legal proceedings and settlement expenses and restructuring charges in the amounts of $0.6 million and $0.5 million, respectively.

      Adjusted EBITDA for the third quarter of 2010 improved to 20.9% of net revenues versus 17.8% for the same period in the prior year.  The Company's improved operating performance during the third quarter of 2010 reflects substantial progress on operating initiatives related to leveraging technology and offshore production resources as well as the Company's progress in successfully integrating the Spheris acquisition.  The impact of cost savings and synergies which we have implemented since the Spheris acquisition are expected to yield $7.0 million of cost savings in the fourth quarter of 2010 representing an annualized savings of $28.0 million.  Of these savings $4.0 million were realized during the quarter ended September 30, 2010.

      Net income for the third quarter of 2010 was $9.0 million or $0.24 per diluted share compared to $9.7 million and $0.26 per diluted share reported in the prior year comparable period.

      Year-To-Date Results

      Net revenues increased $41.2 million, or 17.7%, to $274.4 million for the nine months ended September 30, 2010 compared with $233.3 million for the nine months ended September 30, 2009. The acquisition of Spheris contributed $58.2 million in net revenues for the nine months ended September 30, 2010 versus the same period in the prior year.  This increase was offset by a decrease in legacy maintenance services revenues which were $12.9 million and $16.0 million for the nine months ended September 30, 2010 and 2009, respectively.  Current year net revenues were also unfavorably impacted by effects of lower average pricing of transcription service revenues.

      As a percentage of net revenues, cost of revenues decreased to 67.5% for the nine months ended September 30, 2010 from 67.7% for the same period in 2009.  This improvement was achieved through leveraging speech recognition technologies and increased offshore production as well as overhead savings realized as a result of the Spheris integration efforts.  The increase in cost of revenues versus the prior year period was primarily due to direct incremental costs associated with the incremental Spheris volumes as well as a nonrecurring $1.2 million credit during 2009 related to medical claims costs, which also impacted prior year margin percentages.  

      Total operating costs and expenses increased by 14.9% to $249.2 million for the nine-month period ended September 30, 2010 from $216.9 million in the prior year comparable period primarily due to the inclusion of incremental direct costs of revenues associated with the acquisition of Spheris and $6.5 million of acquisition related costs.  Amortization expense increased by $3.7 million during the current year period versus the same comparable period in the prior year primarily due to amortization of acquired intangible assets associated with the acquisition of Spheris.  Also included for the nine-month period ended September 30, 2010 were legal proceedings and settlement expenses and restructuring charges in the amount of $2.8 million and $1.4 million, respectively.

      Adjusted EBITDA as a percentage of net revenues was 18.8% for the nine months ended September 30, 2010 versus 17.1% for the same prior year period.  The Company's improved operating performance during the nine months ended September 30, 2010 reflects substantial progress in operating initiatives related to leveraging technology and offshore production resources as well as the Company's progress in successfully integrating the Spheris acquisition.  

      Net income for the nine-months ended September 30, 2010 was $17.2 million or $0.46 per diluted share compared to $17.4 million and $0.46 per diluted share for the prior year comparable period.

      In addition to the United States generally accepted accounting principles, or GAAP, results provided throughout this document, MedQuist has provided Adjusted EBITDA data that is a non-GAAP financial measure. Adjusted EBITDA is Net income excluding taxes, interest, equity in income of an affiliated company, depreciation, amortization, cost of legal proceedings and settlements, acquisition related charges, restructuring charges and certain non-recurring accrual reversals.

      Management believes that this non-GAAP financial measure used to manage the business may provide our investors with useful information in addition to the GAAP financial measures presented here. The tables attached to this press release include a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP financial measure and a description of why we believe the non-GAAP financial measure is useful to investors.

      Subsequent Events

      As previously announced, on October 14, 2010, the Company completed a refinancing program whereby the Company secured $310.0 million of financing, consisting of a $225.0 million senior secured credit facility, which includes a $200.0 million term loan and an undrawn $25.0 million revolving credit facility, and $85.0 million aggregate principal amount of senior subordinated notes.  The proceeds were used to repay debt incurred related to prior acquisitions and to pay a special cash dividend of $4.70 per share of common stock to the Company's shareholders.  

      In October 2010, MedQuist sold its ownership of A-Life Medical Inc. ("A-Life") in return for cash consideration of $23.8 million.  We anticipate recognition of a gain on the sale of approximately $9.6 million and to receive approximately $19.1 million of cash from the sale during November of 2010 and the residual during 2012.  MedQuist's investment in A-Life has been accounted for under the equity method and therefore the sale does not impact either revenues or Adjusted EBITDA.  Upon receipt of our cash from the A-life sale, we expect to have approximately $40.0 million in cash and approximately $285.0 million in debt.

      On October 18, 2010, CBaySystems Holdings Limited ("CBay Holdings"), the parent of CBay, Inc, the holder of 69.5% of the outstanding common stock of MedQuist, filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed public offering of its common stock in the United States. CBay Holdings also filed a registration statement on Form S-4 with the SEC relating to a proposed exchange offer pursuant to which CBay Holdings expects to offer to exchange shares of CBay Holdings  common stock for outstanding shares of MedQuist common stock. MedQuist will not be a party to the proposed exchange offer.  On September 30, 2010, certain of MedQuist's noncontrolling shareholders entered into an exchange agreement (the "MedQuist Exchange") with CBay Holdings, pursuant to which those shareholders will receive 4.2459 CBay Holdings shares of common stock for each MedQuist share of common stock, subject to certain adjustments relating to the level of MedQuist's net debt at closing of the MedQuist Exchange, and will enter into a stockholders agreement with CBay Holdings that, among other things, provides them with registration rights and contains provisions regarding their voting in the election of CBay Holdings' directors. The closing under the MedQuist Exchange is conditioned upon the listing of CBay Holdings' shares on the NASDAQ Stock Market the completion of the proposed public offering by CBay Holdings in the United States by January 31, 2011, the reincorporation of CBay Holdings as a Delaware corporation and other conditions. MedQuist is not a party to the MedQuist Exchange.

      Forward-Looking Statements

      This report contains forward-looking statements that are based on current expectations, estimates, forecasts and projections about us, the industry in which we operate and other matters, as well as management's beliefs and assumptions and other statements regarding matters that are not historical facts. These statements include, in particular, statements about our plans, strategies and prospects. For example, when we use words such as "projects," "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "should," "would," "could," "will," "opportunity," "potential" or "may," variations of such words or other words that convey uncertainty of future events or outcomes, we are making forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are only predictions and, as such, are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. For a discussion of these risks, uncertainties and assumptions, any of which could cause our actual results to differ from those contained in the forward-looking statement, see the section of MedQuist's Annual Report on Form 10-K for the year ended December 31, 2009, entitled "Risk Factors" and discussions of potential risks and uncertainties in MedQuist's subsequent filings with the Securities and Exchange Commission.

      MedQuist Inc. and Subsidiaries

      Consolidated Statements of Operations

      (In thousands, except per share amounts)

      Unaudited














      Three months ended


      Nine months ended




      September 30,


      September 30,




      2010


      2009


      2010


      2009











      Net revenues

      $ 102,933


      $ 76,836


      $ 274,442


      $ 233,251











      Operating costs and expenses:









      Cost of revenues

      68,427


      52,768


      185,350


      157,993


      Selling, general and administrative

      9,352


      7,930


      28,169


      25,819


      Research and development

      3,681


      2,439


      9,274


      7,235


      Depreciation

      2,822


      2,197


      7,518


      7,418


      Amortization of intangible assets

      3,394


      1,518


      8,229


      4,533


      Cost of legal proceedings and settlements

      631


      1,382


      2,783


      13,440


      Acquisition and integration related charges

      842


      -


      6,501


      -


      Restructuring charges

      495


      481


      1,425


      481













      Total operating costs and expenses

      89,644


      68,715


      249,249


      216,919













      Operating income

      13,289


      8,121


      25,193


      16,332











      Equity in income of affiliated company

      70


      2,154


      616


      2,582

      Interest income (expense)

      (2,927)


      (29)


      (6,706)


      36













      Income before income taxes

      10,432


      10,246


      19,103


      18,950











      Income tax provision

      1,461


      542


      1,908


      1,556













      Net income

      $     8,971


      $   9,704


      $   17,195


      $   17,394











      Net income per share:









      Basic

      $       0.24


      $     0.26


      $       0.46


      $       0.46


      Diluted

      $       0.24


      $     0.26


      $       0.46


      $       0.46











      Weighted average shares outstanding:









      Basic

      37,556


      37,556


      37,556


      37,556


      Diluted

      37,556


      37,560


      37,556


      37,556



      MedQuist Inc. and Subsidiaries

      Consolidated Balance Sheets

      (In thousands)

      Unaudited








      September 30,


      December 31,



      2010


      2009

      Assets





      Current assets:






      Cash and cash equivalents


      $   21,894


      $   25,216


      Accounts receivable, net of allowance of $3,305 and $3,159, respectively


      65,026


      43,627


      Income tax receivable


      35


      772


      Other current assets


      9,311


      4,940



      Total current assets


      96,266


      74,555







      Property and equipment, net


      14,975


      11,772

      Goodwill


      88,951


      40,813

      Other intangible assets, net


      81,984


      36,307

      Deferred income taxes


      1,525


      1,396

      Other assets


      14,788


      9,818









      Total assets


      $ 298,489


      $ 174,661







      Liabilities and Shareholders' Equity





      Current liabilities:






      Current portion of long term debt (subsequently refinanced)


      $   25,000


      $           -


      Accounts payable


      6,275


      8,687


      Accrued expenses


      24,374


      21,490


      Accrued compensation


      17,133


      12,432


      Current portion of lease obligations


      1,229


      -


      Related party payable


      6,681


      1,362


      Deferred revenue


      10,762


      10,854



      Total current liabilities


      91,454


      54,825

      Long term debt (subsequently refinanced)


      68,898



      Deferred income taxes


      5,419


      3,240

      Other non-current liabilities


      874


      1,848







      Commitments and contingencies





      Shareholders' equity:






      Common stock - no par value; authorized 60,000 shares;






      37,556 and 37,556 shares issued and outstanding, respectively


      237,993


      237,848


      Accumulated deficit


      (108,659)


      (125,854)


      Accumulated other comprehensive income


      2,510


      2,754









      Total shareholders' equity


      131,844


      114,748









      Total liabilities and shareholders' equity


      $ 298,489


      $ 174,661



      MedQuist Inc. and Subsidiaries

      Consolidated Statements of Cash Flows

      (In thousands)

      Unaudited








      Nine months ended



      September 30,



      2010


      2009

      Operating activities:





      Net income


      $  17,195


      $ 17,394

      Adjustments to reconcile net income to cash provided by operating activities:





      Depreciation and amortization


      15,747


      11,951

      Equity in income of affiliated company


      (616)


      (2,582)

      Deferred income taxes


      2,021


      662

      Stock option expense


      145


      144

      Noncash interest expense


      328


      -

      Provision for doubtful accounts


      1,571


      230

      Loss on disposal of property and equipment


      -


      27

      Changes in operating assets and liabilities:





      Accounts receivable


      (554)


      6,847

      Income tax receivable


      733


      (50)

      Other current assets


      (1,216)


      3,467

      Other non-current assets


      869


      (34)

      Accounts payable


      1,129


      (351)

      Accrued expenses and Related party payable


      (6,910)


      (3,744)

      Accrued compensation


      878


      2,959

      Deferred revenue


      (170)


      (4,107)

      Other non-current liabilities


      (1,056)


      168

      Net cash provided by operating activities


      $  30,094


      $ 32,981






      Investing activities:





      Purchase of property and equipment


      (3,793)


      (3,603)

      Capitalized software


      (3,806)


      (1,846)

      Investment in affiliated company


      -


      (852)

      Acquisitions, net of cash acquired


      (98,661)


      -

      Net cash used in investing activities


      (106,260)


      (6,301)






      Financing activities:





      Borrowing on credit line


      100,000


      -

      Repayment of debt


      (20,000)


      -

      Dividends paid


      -


      (49,949)

      Debt issuance costs


      (7,031)


      (1,171)

      Payments on lease obligations


      (129)


      -

      Net cash provided by (used in) financing activities


      72,840


      (51,120)






      Effect of exchange rate changes


      4


      199






      Net decrease in cash and cash equivalents


      (3,322)


      (24,241)






      Cash and cash equivalents - beginning of period


      25,216


      39,918






      Cash and cash equivalents - end of period


      $  21,894


      $ 15,677






      Supplemental cash flow information:










      Cash paid for income taxes


      $      (318)


      $      241

      Accommodation payments paid with credits


      $          -


      $      103

      Noncash debt incurred in connection with the Spheris acquisition


      $  13,570


      $         -



      MedQuist Inc. and Subsidiaries

      Reconciliation of GAAP financial measures to the non-GAAP measures

      Adjusted EBITDA

      (In thousands)

      Unaudited











      Three months ended


      Nine months ended


      September 30,  


      September 30, 


      2010


      2009


      2010


      2009









      Net income

      $   8,971


      $   9,704


      $ 17,195


      $ 17,394









      Add: Income tax provision

      1,461


      542


      1,908


      1,556









      Add (Less): Interest expense (income)

      2,927


      29


      6,706


      (36)









      Add: Depreciation

      2,822


      2,197


      7,518


      7,418









      Add: Amortization of intangible assets

      3,394


      1,518


      8,229


      4,533









      Add: Restructuring charges

      495


      481


      1,425


      481









      Add: Acquisition and integration related charges

      842


      -


      6,501


      -









      Add: Cost of legal proceedings and settlements

      631


      1,382


      2,783


      13,440









      Less:  Accrual reversals

      -


      -


      -


      (2,254)









      Less: Equity in income of affiliated company

      (70)


      (2,154)


      (616)


      (2,582)









      Adjusted EBITDA

      $ 21,473


      $ 13,699


      $ 51,649


      $ 39,950









      Adjusted EBITDA as a % of Net revenue

      20.9%


      17.8%


      18.8%


      17.1%



      The impact of cost savings and synergies resulting from the Spheris acquisition, which we have implemented since the Spheris acquisition are expected to yield $7.0 million of cost savings in the fourth quarter of 2010 representing an annualized savings of $28.0 million.  Of these savings $4.0 million were realized during the three months ended September 30, 2010 and $4.9 million were realized in the nine months ended September 30, 2010.

      Adjusted EBITDA is a financial measure not computed in accordance with United States generally accepted accounting principles, or GAAP. The Company believes that this non-GAAP measure, when presented in conjunction with comparable GAAP measures, is useful to both management and investors in analyzing the Company's ongoing business and operating performance. The Company believes that providing the non-GAAP information to investors, in addition to the GAAP presentation, allows investors to view the Company's financial results in the way that management views financial results. Management believes Adjusted EBITDA is useful as supplemental measures of the Company's financial results because it removes costs not related to the Company's operating performance. Management believes that Adjusted EBITDA should be considered in addition to, but not as a substitute for items presented in accordance with GAAP that are presented in this press release. A reconciliation of Net income to Adjusted EBITDA is provided above.

      SOURCE MedQuist Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.